UK markets open in 3 hours 6 minutes

Endonovo Therapeutics, Inc. (ENDV)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0014+0.0000 (+3.70%)
At close: 03:50PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
140.242
140.242
135.355
73.105
165.796
-
Cost of revenue
7.84
7.84
9.99
14.985
65.369
-
Gross profit
132.402
132.402
125.365
58.12
100.427
-
Operating expenses
Total operating expenses
3,052
3,052
3,390
2,285
3,013
-
Operating income or loss
-2,919
-2,919
-3,264
-2,227
-2,912
-
Interest expense
1,282
1,282
1,322
941.566
2,083
-
Total other income/expenses net
11,126
11,126
-13,889
63.219
4,600
-
Income before tax
6,925
6,925
-18,475
-3,105
-395.584
-
Income tax expense
0
0
0
0
0
-
Income from continuing operations
6,925
6,925
-18,475
-3,105
-395.584
-
Net income
6,925
6,925
-18,475
-3,105
-395.584
-
Net income available to common shareholders
6,925
6,925
-18,475
-3,105
-395.584
-
Basic EPS
-0.05
-
-0.13
-0.05
-0.03
-24.83
Diluted EPS
-0.07
-
-0.13
-0.05
-0.03
-24.83
Basic average shares
254,570
-
139,207
59,837
12,216
697.305
Diluted average shares
1,060,380
-
139,207
59,837
12,216
697.305